pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
TARA-002
Unspecified Rare Disease
$TARAProtara Therapeutics, Inc.
0 catalysts
Phase 2
TAS-0728
Solid Tumor
Taiho Pharmaceutical Co Ltd
0 catalysts
Phase 2
TB-006
Alzheimer's Disease
TrueBinding Inc
0 catalysts
Phase 2
TBA-7371
Pulmonary Tuberculosis
← prev
page 27 of 50
next →
131
Pain89
Neurology1
Decaprenylphosphoryl-beta-D-ribose oxidase
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
TDM-105795
Androgenic Alopecia
Technoderma Medicines Inc
0 catalysts
Phase 2
TDM-180935
Atopic Dermatitis (Atopic Eczema)
Technoderma Medicines Inc
0 catalysts
Phase 2
TERN-501
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$TERNTerns Pharmaceuticals, Inc.
0 catalysts
Phase 2
TERN-701
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$TERNTerns Pharmaceuticals, Inc.
0 catalysts
Phase 2
TEV-408
Celiac Disease
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Phase 2
TG-01
Pancreatic Cancer
Prostaglandin G/H synthase 2
Circio Holding ASA
0 catalysts
Phase 2
TG-1042
Basal Cell Carcinoma (Basal Cell Epithelioma)
Stamford Pharmaceuticals Inc
0 catalysts
Phase 2
TG-4050
Myvac
Head And Neck Cancer
Transgene SA
0 catalysts
Phase 2
TH-103
Wet (Neovascular / Exudative) Macular Degeneration
$KLRSKalaris Therapeutics, Inc.
0 catalysts
Phase 2
TILT-123
Ovarian Cancer
TILT Biotherapeutics Ltd
0 catalysts
Phase 2
TLD-1433
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Theralase Technologies Inc
0 catalysts
Phase 2
TLL-018
Plaque Psoriasis (Psoriasis Vulgaris)
Hangzhou Highlightll Pharmaceutical Co Ltd
0 catalysts
Phase 2
TLP-02
Metablok
Acute Respiratory Distress Syndrome
Arch Biopartners Inc
0 catalysts
Phase 2
TLX-250
Metastatic Renal Cell Carcinoma
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 2
TMB-365
Human Immunodeficiency Virus (HIV) Infections (AIDS)
TaiMed Biologics Inc
0 catalysts
Phase 2
TMB-365 + TMB-380
Human Immunodeficiency Virus (HIV) Infections (AIDS)
TaiMed Biologics Inc
0 catalysts
Phase 2
TN-201
Hypertrophic Cardiomyopathy
$TNYATenaya Therapeutics, Inc.
0 catalysts
Phase 2
TN-401
Cardiomyopathy
$TNYATenaya Therapeutics, Inc.
0 catalysts
Phase 2
TNG-260
Cervical Cancer
$TNGXTango Therapeutics, Inc.
0 catalysts
Phase 2
TNG-456
Bladder Cancer
$TNGXTango Therapeutics, Inc.
0 catalysts
Phase 2
TP-102
Diabetic Foot Ulcers
Lxbio Pharmaceuticals SA
0 catalysts
Phase 2
TPX-100
Osteoarthritis
OrthoTrophix Inc
0 catalysts
Phase 2
TRI-611
Non-Small Cell Lung Cancer
TRIANA Biomedicines Inc
0 catalysts
Phase 2
TRK-950
Adenocarcinoma Of The Gastroesophageal Junction
Toray Industries Inc
0 catalysts
Phase 2
TRN-261
Pain
Tris Pharma Inc
0 catalysts
Phase 2
TRX-103
Crohn's Disease (Regional Enteritis)
Tr1X Inc
0 catalysts